Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient manageme...
Manufactured by
China
NewScen Coast Bio-Pharmaceutical Co., Ltd., established in 2003, is a leading POCT manufacturer listed on China's NEEQ (Stock Code: 872334). The company produces rapid diagnostic products covering cardiac markers, infection, tumor, and infectious disease testing, serving over 110 domestic medical institutions and exporting to 20+ countries. In 2019, the company established China's first automated microfluidic chip production line for immunoassay applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 2 relevant products
Lumigenex (Suzhou) Co., Ltd
China · 3 relevant products
72 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 113 closest product alternatives
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.
Lumigenex (Suzhou) Co., Ltd · China
A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.
110 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products